Life Sciences Tools

Showing 873 articles
Business

Oxford Lane Capital Cuts Payout Amid Market Turbulence, NAV Takes a Hit

Oxford Lane Capital (OXLC) reported a challenging third fiscal quarter, marked by a significant drop in net asset value and investment income, prompting management to reduce its monthly distribution. The firm cited volatile conditions in the CLO and leveraged loan markets as key headwinds, while outlining a strategy to preserve capital for opportunistic investments.

Business

W. P. Carey's Valuation Conundrum: A Deep Dive After a 31% Surge

Shares of diversified REIT W. P. Carey have delivered a robust 31% return over the past year, prompting investors to question whether the current price near $69 represents fair value or an opportunity. A closer look reveals a complex picture where traditional metrics and cash flow models tell conflicting stories.